LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

An Innovative Approach to Q-TOF High Resolution Accurate Mass Analyte Screening Using an Improved Software Algorithm and Screener Tool

Posters | 2023 | Agilent Technologies | ASMSInstrumentation
Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Industries
Other
Manufacturer
Agilent Technologies

Summary

Importance of the Topic


High-resolution, accurate mass screening of complex samples is essential for reliable detection of a large number of targets and suspects in various fields including pharmaceutical QA/QC, forensic toxicology and environmental monitoring. The development of robust data mining algorithms is critical to manage matrix variability, broad concentration ranges and to minimize false positive/negative outcomes in routine analyses.

Study Objectives and Overview


This study aimed to demonstrate a proof of principle for screening a panel of over 200 analytes and suspects in a single eight-minute LC–Q-TOF analysis. The improved software algorithm SureMass and an interactive Screener Tool were evaluated for reproducibility, mass accuracy (<5 ppm) and data processing speed across high and low concentration controls.

Methodology and Instrumentation


  • Chromatography: 8 min reverse phase gradient on Poroshell 120 EC C18 column (100 × 2.1 mm). Mobile phases: 0.01% formic acid with 5 mM ammonium formate in water (A) and methanol (B).
  • Gradient: 10%→95% methanol over 8 min.
  • Mass spectrometry: Agilent 6546 Q-TOF LC/MS in positive mode; scan rates 3 Hz (MS-only) and 9 Hz (All Ions at 0, 20, 30 eV).
  • Source settings: AJS-ESI at 0.5 mL/min, nozzle voltage 500 V, sheath gas 360 °C/11 L/min, dry gas 300 °C/10 L/min, nebulizer 55 psi, capillary 3750 V.
  • Data processing: SureMass algorithm for profile data, extracting ridges and features by combining monoisotopic mass, isotope spacing, abundance and retention time information.

Main Results and Discussion


  • Near 100% identification rate for 200+ targets with mass match scores in the high 90% range for both low and high concentration controls (N=10 replicate injections).
  • Mass accuracy below 5 ppm across all targets, even at very low and very high abundances, demonstrating robust performance of the SureMass algorithm in both MS-only and All Ions acquisition modes.
  • SureMass effectively handles saturation effects in centroided data, avoiding false negatives due to split peaks or mass shifts.
  • The Screener Tool’s color-coded interface (green/amber/red) simplifies batch review, significantly reducing analyst evaluation time.
  • Data processing speed is substantially faster with SureMass, supporting large target lists without compromising accuracy.

Benefits and Practical Applications


  • Comprehensive screening of hundreds of analytes in a single, short analysis run.
  • Consistent high mass accuracy supports confident identification in QA/QC and forensic workflows.
  • Reduced false positive/negative rates enhance data reliability in regulatory environments.
  • User-friendly Screener Tool streamlines data review and reporting.
  • Compatibility with both MS-only and All Ions acquisition offers flexibility for different application needs.

Future Trends and Opportunities for Use


  • Expansion of target databases to include emerging contaminants and novel psychoactive substances.
  • Integration of machine learning to further refine feature extraction and reduce manual review.
  • Application in diverse fields such as environmental screening, food safety and clinical research.
  • Development of real-time processing for on-the-fly screening in high-throughput laboratories.

Conclusion


The SureMass data mining algorithm, combined with the Agilent 6546 Q-TOF LC/MS and Screener Tool, offers a rapid, accurate and reproducible platform for high-resolution screening of extensive analyte panels. Its robust performance, user-friendly interface and high mass accuracy make it an effective solution for routine analytical workflows requiring comprehensive screening.

Reference


  1. Karen E. Yannell and Manuel Gomez; Agilent Technologies, Inc.; Publication 5994-1744EN.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Screening and semi-quantitation of 212 fentanyl analog compounds by the Orbitrap Exploris 120 mass spectrometer
TECHNICAL NOTE 66050 Screening and semi-quantitation of 212 fentanyl analog compounds by the Orbitrap Exploris 120 mass spectrometer Authors: Stephanie Samra, Kerry Hassell, and Kristine Van Natta Thermo Fisher Scientific, San Jose, CA Keywords: Orbitrap Exploris 120 MS, Tox Explorer…
Key words
fentanyl, fentanylpara, parafuranyl, furanylmethyl, methylfluoro, fluoroortho, orthomethoxy, methoxymeta, metamethoxyacetyl, methoxyacetylcyclopropyl, cyclopropylnorfentanyl, norfentanylacrylfentanyl, acrylfentanylbutyryl, butyrylloi, loiacetyl
Confident Fentanyl Screening in Urine by HRAM Orbitrap Mass Spectrometer Analysis
Confident Fentanyl Screening in Urine by HRAM Orbitrap Mass Spectrometer Analysis Stephanie N. Samra, Kerry Hassell, Kristine Van Natta, Pengxiang Yang, Tanis Correa, Thermo Fisher Scientific, San Jose, CA 95134 ABSTRACT Purpose: Demonstrate the screening capability of a modified Thermo…
Key words
fentanyl, fentanylpara, paramethyl, methylfuranyl, furanylfluoro, fluoroortho, orthomethoxy, methoxymeta, metamethoxyacetyl, methoxyacetylcyclopropyl, cyclopropylnorfentanyl, norfentanylacrylfentanyl, acrylfentanylbutyryl, butyrylacetyl, acetylchloro
Screening and semi-quantification of fentanyls in human urine using high-resolution Orbitrap mass spectrometry for clinical research or forensic toxicology
TECHNICAL NOTE 73391 Screening and semi-quantification of fentanyls in human urine using high-resolution Orbitrap mass spectrometry for clinical research or forensic toxicology Authors: Magnus Olin, Thermo Fisher Scientific, Hägersten, Sweden Yufang Zheng, Unilabs, Eskilstuna, Sweden Keywords: Fentanyls, urine, screening, Orbitrap,…
Key words
fentanyl, fentanylfuranylnorfentanyl, furanylnorfentanylacetylnorfentanyl, acetylnorfentanylfuranylfentanyl, furanylfentanylacrylfentanyl, acrylfentanylocfentanil, ocfentanilfluorofentanyl, fluorofentanylacetylfentanyl, acetylfentanylcarfentanil, carfentanilbutyrylfentanyl, butyrylfentanylnorfentanyl, norfentanylortho, orthoanalogs, analogsurine, urinemethylfentanyl
A Comprehensive Approach to Targeted and Untargeted Screening Methodology for Emerging Synthetic Fentanyl Analogues
Application Note Clinical Research A Comprehensive Approach to Targeted and Untargeted Screening Methodology for Emerging Synthetic Fentanyl Analogues High Resolution Accurate Mass Spectrometry Authors Dr. Julie Cichelli, Carrie J. Adler, and Dr. Jim Lau Agilent Technologies, Inc. Abstract In recent…
Key words
hydrochloride, hydrochloridefentanyl, fentanylpara, parafuranyl, furanylortho, orthomethyl, methylfluoro, fluoromethoxy, methoxymethoxyacetyl, methoxyacetylacrylfentanyl, acrylfentanylcyclopropyl, cyclopropylbutyryl, butyrylmeta, metamass, masschloro
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike